A systems view of spliceosomal assembly and branchpoints with iCLIP. by Briese, Michael et al.
A systems view of spliceosomal assembly and branchpoints 
with iCLIP
Michael Briese#1,2, Nejc Haberman#3,4, Christopher R. Sibley#1,4,5,6, Rupert Faraway3,4, 
Andrea S. Elser3,4, Anob M. Chakrabarti3,7, Zhen Wang1, Julian König1,8, David Perera9, 
Vihandha O. Wickramasinghe9,10, Ashok R. Venkitaraman9, Nicholas M. Luscombe3,7,11, 
Luciano Saieva12,13, Livio Pellizzoni12, Christopher W.J. Smith14, Tomaž Curk15, Jernej 
Ule1,3,4,§
1MRC Laboratory of Molecular Biology, Cambridge, UK
2Institute of Clinical Neurobiology, University of Wuerzburg, Wuerzburg, Germany
3The Francis Crick Institute, London, UK
4Department of Neuromuscular Disease, UCL Institute of Neurology, London, UK
5Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK
6Institute of Quantitative Biology, Biochemistry and Biotechnology, Edinburgh University, UK
7Department of Genetics, Environment and Evolution, UCL Genetics Institute, London, UK
8Institute of Molecular Biology (IMB) GmbH, Mainz, Germany
9MRC Cancer Unit at the University of Cambridge, Cambridge, UK
10RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia
11Okinawa Institute of Science & Technology Graduate University, Okinawa, Japan
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
§Corresponding author: Jernej Ule: jernej.ule@crick.ac.uk. 
Reporting Summary
Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Code availability
The code to identify BPs from spliceosome iCLIP reads is publicly available at the GitHub repository (https://github.com/nebo56/
branch-point-detection-2).
Data availability
The spliceosome iCLIP data generated and analyzed during the current study are available on EBI ArrayExpress under the accession 
number E-MTAB-8182, and are also available in raw and processed format on https://imaps.genialis.com/iclip. Additional datasets 
used in this study are listed in Supplementary Data Set 4. Source Data for Fig. 1c are available online. Other data are available upon 
request.
Author contributions
M.B., C.R.S. and J.U. conceived the project, designed the experiments and wrote the manuscript, with assistance of all co-authors. 
M.B., C.R.S., Z.W., R.F. and A.S.E. performed experiments, with assistance from J.U., J.K. and C.W.S.. N.H. performed most 
computational analyses, with assistance from C.R.S., T.C., R.F., A.M.C. and N.M.L.. V.O.W., D.P. and A.R.V. provided crosslinked 
pellets from wild-type and PRPF8-depleted Cal51 cells. L.S. and L.P. developed and characterized the monoclonal antibody 18F6.
Competing interests
The authors declare no competing interests.
Europe PMC Funders Group
Author Manuscript
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 March 30.
Published in final edited form as:
Nat Struct Mol Biol. 2019 October ; 26(10): 930–940. doi:10.1038/s41594-019-0300-4.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
12Center for Motor Neuron Biology and Disease, Department of Pathology and Cell Biology, 
Columbia University, New York, NY, USA
13Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK
14Department of Biochemistry, University of Cambridge, Cambridge, UK
15Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia
#
 These authors contributed equally to this work.
Abstract
Studies of spliceosomal interactions are challenging due to their dynamic nature. Here we 
employed spliceosome iCLIP, which immunoprecipitates SmB along with snRNPs and auxiliary 
RNA binding proteins (RBPs), to map spliceosome engagement with pre-mRNAs in human cell 
lines. This revealed seven peaks of spliceosomal crosslinking around branchpoints (BPs) and 
splice sites. We identified RBPs that crosslink to each peak, including known and candidate 
splicing factors. Moreover, we detected use of over 40,000 BPs with strong sequence consensus 
and structural accessibility, which align well to nearby crosslinking peaks. We show how the 
position and strength of BPs affect the crosslinking patterns of spliceosomal factors, which bind 
more efficiently upstream of strong or proximally located BPs, and downstream of weak or 
distally located BPs. These insights exemplify spliceosome iCLIP as a broadly applicable method 
for transcriptomic studies of splicing mechanisms.
Introduction
Splicing is a multi-step process in which small nuclear ribonucleoprotein particles (snRNPs) 
and associated splicing factors bind at specific positions around intron boundaries in order to 
assemble an active spliceosome through a series of remodeling steps. The splicing reactions 
are coordinated by dynamic pairings between different snRNAs, between snRNAs and pre-
mRNA, and by protein-RNA contacts1. Spliceosome assembly begins with ATP-independent 
binding of U1 snRNP at the 5' splice site (ss), and of U2 small nuclear RNA auxiliary factors 
1 and 2 (U2AF1 and U2AF2, also known as U2AF35 and U2AF65) to the 3'ss. ATP-
dependent remodeling then leads to the formation of complex A in which U2 snRNP 
contacts the branchpoint (BP), stabilized through interactions with the U2AF and U2 snRNP 
splicing factor 3 (SF3a and SF3b) complex. Next, U4/U6 and U5 snRNPs are recruited to 
form complex B. The actions of many RNA helicases and pre-mRNA processing factor 8 
(PRPF8) then facilitate rearrangements of snRNP interactions and establishment of the 
catalytically competent Bact and C complexes. These catalyze the two trans-esterification 
reactions leading to lariat formation, intron removal and exon ligation2.
Transcriptome-wide studies of splicing reactions are valuable to unravel the multi-
component and dynamic assembly of the spliceosome on the pre-mRNA substrate3–5. 
Accordingly, “spliceosome profiling” has been developed through affinity purification of the 
tagged U2·U5·U6·NTC complex from Schizosaccharomyces pombe to monitor its 
interactions using a RNA footprinting-based strategy3,4. However, it is unclear if this method 
can be applied to mammalian cells which might be more sensitive to introduction of affinity 
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tags into splicing factors. Furthermore, no method has simultaneously monitored the full 
complexity of the interactions of diverse RBPs on pre-mRNAs from the earliest to the latest 
stages of spliceosomal assembly.
Here, we have adapted the individual nucleotide resolution UV crosslinking and 
immunoprecipitation (iCLIP) method6 to develop spliceosome iCLIP. This approach 
identifies crosslinks of endogenous, untagged spliceosomal factors on pre-mRNAs at 
nucleotide resolution. In a previous study, we demonstrated validity of this approach by 
showing how PRPF8 remodels spliceosomal contacts at 5'ss5. Here, we comprehensively 
characterize spliceosome iCLIP and show that it simultaneously maps the crosslink profiles 
of core and accessory spliceosomal factors that are known to participate across the diverse 
stages of the splicing cycle. Due to iCLIP’s nucleotide precision, we distinguished 7 binding 
peaks corresponding to distinct RBPs that differ in their requirement for ATP or the factor 
PRPF8. Spliceosome iCLIP also purifies intron lariats and identified 132,287 candidate BP 
positions. Compared to BPs identified in previous RNA-seq studies7–9, those identified by 
spliceosome iCLIP contain more canonical sequence and structural features. We further 
examined the binding profiles of spliceosomal RBPs around the BPs. This demonstrates that 
assembly of SF3 and associated spliceosomal complexes tends to be determined by a 
primary BP in most introns, even though alternative BPs are detected by lariat-derived reads 
in RNA-seq. Moreover, we identify complementary roles of U2AF and SF3 complexes in 
BP definition. Taken together, these findings demonstrate the value of spliceosome iCLIP for 
transcriptome-wide studies of BP definition and spliceosomal interactions with pre-mRNAs.
Results
Spliceosome iCLIP identifies interactions between splicing factors, snRNAs and pre-
mRNAs
SmB/B' proteins are part of the highly stable Sm core common to all spliceosomal snRNPs 
except U61. In order to adapt iCLIP for the study of a multi-component machine like the 
spliceosome, we immunopurified endogenous SmB/B' proteins10 using a range of conditions 
with differing stringency of detergents and salt concentrations for the lysis and washing 
steps (Supplementary Table 1, Fig. 1a and Supplementary Fig. 1a,b). First, to enable 
denaturing purification, we generated HEK293 cells stably expressing Flag-tagged SmB and 
employed 6M urea during cell lysis to minimize co-purification of additional proteins11 
(‘stringent’ purification, Supplementary Table 1), followed by dilution of the lysis buffer 
(see Methods) to facilitate immunopurification of SmB via the Flag tag. We observed a 25 
kDa band corresponding to the molecular weight of SmB-RNA complexes, which was 
absent when UV light or anti-Flag antibody were omitted, or when cells not expressing Flag-
SmB were used (Supplementary Fig. 1c). Next, we employed the standard, non-denaturing 
iCLIP condition, which uses a high concentration of detergents in the lysis buffer, and wash 
buffer with 1M NaCl (‘medium’ purification, Supplementary Table 1). This disrupts most 
protein-protein interactions but can preserve stable complexes such as snRNPs, as evident by 
the multiple radioactive bands in addition to the 25 kDa SmB-RNA complex upon treatment 
with low RNase (Fig. 1b). Of note, similar profiles of protein-RNA complexes were 
obtained when using different monoclonal SmB/B' antibodies (Supplementary Fig. 1d). Last, 
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we further decreased the concentration of detergents in the lysis buffer, used 0.1M NaCl in 
the washing buffer (‘mild’ purification, Supplementary Table 1), and employed the low 
RNase treatment that leaves snRNAs generally intact such that they serve as a scaffold for 
purifying the multi-protein spliceosomal complexes (Fig. 1a).
To produce cDNA libraries with spliceosome iCLIP, we immunoprecipitated SmB/B' under 
the three different stringency conditions from lysates of UV-crosslinked cells, and isolated a 
broad size distribution of protein-RNA complexes in order to recover the greatest possible 
diversity of spliceosomal protein-RNA interactions (Fig. 1b and Supplementary Fig. 1c,d). 
An antibody against endogenous SmB/B' was used for medium and mild purification from 
HEK293, K562 and HepG2 cells, and an anti-Flag antibody for stringent purification from 
HEK293 cells expressing Flag-SmB (Supplementary Table 2 and 3). As in previous iCLIP 
studies6, the nucleotide preceding each cDNA was used for all analyses. When stringent 
conditions were used, >75% of iCLIP cDNAs mapped to snRNAs, likely corresponding to 
the direct binding of Flag-SmB (Fig. 1c). However, the proportion of snRNA crosslinking 
reduced to ~40-60% under mild and medium conditions, with a corresponding increase of 
crosslinking to introns and exons that likely reflects binding of snRNP-associated proteins to 
pre-mRNAs (Fig. 1a,c).
Spliceosome iCLIP identifies seven crosslinking peaks on pre-mRNAs
Assembly of the spliceosome on pre-mRNA is guided by three main landmarks: the 5'ss, 3'ss 
and BP. Therefore, we evaluated if spliceosomal crosslinks are located at specific positions 
relative to splice sites and computationally predicted BPs12. For this purpose we performed 
spliceosome iCLIP from human Cal51 cells, which we have previously used as a model 
system to study the roles of spliceosomal factors in cell cycle5. RNA maps of summarized 
spliceosomal crosslinking revealed 7 peaks around these landmarks (Fig. 2a). Importantly, 
similar positional patterns were also seen in HEK293, K562 and HepG2 cell lines 
(Supplementary Fig. 2a). The centers of the peaks were 15 nt upstream of the 5'ss (peak 1), 
10 nt downstream of the 5'ss (peak 2), 31 nt downstream of the 5'ss (peak 3), 26 nt upstream 
of the BP (peak 4), 20 nt upstream of the BP (peak 5), 11 nt upstream of the 3'ss (peak 6) 
and 3 nt upstream of the 3'ss (peak 7). We also observed alignment of cDNA starts to the 
start of the intron and the BPs, which we refer to as positions A and B, respectively (Fig. 2a 
and Supplementary Fig. 2a). The crosslinking enrichment at most peaks was generally 
stronger under the mild condition, especially at the 3'ss (Supplementary Fig. 2a). This 
indicates that spliceosome iCLIP performed under mild conditions is most suitable for 
investigating spliceosomal assembly on pre-mRNAs.
Spliceosome iCLIP monitors multiple stages of spliceosomal remodeling
Next, we investigated whether spliceosome iCLIP is able to monitor spliceosome assembly 
at different stages during the splicing cycle. For this purpose we knocked down (KD) PRPF8 
in Cal51 cells (Supplementary Fig. 2b) and performed spliceosome iCLIP under mild 
conditions. As an integral component of the U4/U6.U5 tri-snRNP, PRPF8 is essential for 
both catalytic reactions1. We previously showed that PRPF8 is required for efficient 
spliceosomal assembly at 5'ss5. Here, we additionally find that PRPF8 is essential for 
efficient spliceosomal assembly at peaks 4 and 5 (Fig. 2a). Moreover, we also observed a 
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major decrease of reads truncating at the positions A and B, whereas crosslinking at peaks 2 
and 6 is increased upon PRPF8 KD.
To further investigate whether spliceosome iCLIP can monitor distinct stages of the splicing 
reaction, we performed an in vitro splicing assay in which an exogenous pre-mRNA splicing 
substrate was incubated with HeLa nuclear extract in the presence or absence of ATP. ATP is 
required for the progression of early, ATP-independent, spliceosomal complexes to later 
assembly stages mediating the catalytic splicing reactions. The RNA substrate was produced 
by in vitro transcription of a minigene construct containing a short intron and flanking exons 
from the human C6orf10 gene. Gel electrophoresis analysis confirmed that the minigene 
RNA was efficiently spliced in vitro in an ATP-dependent manner (Supplementary Fig. 2c). 
We performed spliceosome iCLIP from the splicing reactions using the mild purification 
condition (Supplementary Fig. 2d). Following sequencing, the reads mapping to the 
exogenous splicing substrate or spliced product represented ~1%, whereas the remaining 
reads were derived from endogenous RNAs present in the nuclear extract (Supplementary 
Table 4). The spliced product was detected with exon-exon junction reads primarily in the 
presence of ATP (364 reads in +ATP vs. 5 reads in -ATP condition) (Supplementary Fig. 2e 
and Supplementary Table 4). As expected given that the spliceosome rapidly disassembles 
upon completion of the splicing reaction, very few reads mapped to the spliced (364 reads) 
compared to unspliced substrate (48,584 reads) (Supplementary Table 4) in the +ATP 
condition. It should be considered, however, that some reads from exogenous minigene 
could represent RNA that did not enter the splicing pathway.
We visualized crosslinking on the substrate RNA, and marked positions that correspond to 
peaks on the transcriptome-wide RNA maps (Fig. 2b). Whilst crosslinking peaks on a 
metagene plot might not necessarily be representative of individual splicing substrates, we 
nevertheless observed crosslinking in corresponding regions of the C6orf10 substrate 
(comparing Fig. 2a and 2b). When comparing crosslinking in the presence or absence of 
ATP, an unchanged crosslinking profile was seen in regions of peaks 1, 2, 6 and 7, indicating 
these are ATP-independent contacts of early spliceosomal factors. In contrast, the presence 
of ATP led to a ~11 fold increase of crosslinking in the region upstream of the BP where the 
PRPF8-dependent peaks 4 and 5 are located on endogenous transcripts (Fig. 2b). This 
indicates that spliceosome iCLIP detects pre-mRNA binding of factors contributing to early, 
ATP-independent and late, ATP-dependent stages of spliceosomal assembly.
Following crosslinking, the peptide that remains bound to the RNA after RBP digestion will 
normally terminate reverse transcription to produce so-called ‘truncated cDNAs’13–15. 
Accordingly, analysis of data from iCLIP and derived methods, such as eCLIP16, generally 
refer to the nucleotide preceding the iCLIP read on the reference genome as the ‘crosslink 
site’. However, in spliceosome iCLIP we additionally expect cDNAs that truncate at the 
three-way junction formed by intron lariats, where the 5' end of the intron is linked via a 
2'-5' phosphodiester bond to the BP (Fig. 2c). Following RNase digestion, such lariat three-
way-junction RNAs present two available 3' ends for ligation of adapters, such that cDNAs 
can truncate at the BP (i.e. position B) or at the start of the intron (i.e. position A). 
Interestingly, the medium purification condition was optimal to produce cDNAs truncating 
at positions A and B (Supplementary Fig. 2a), possibly because spliceosomal C complexes 
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containing lariat intermediates are known to be stable under high-salt conditions17. Note that 
peaks A and B are higher in HEK293 compared to HepG2 and K562 cells under medium 
purification conditions, and likely reflect differences in lariat co-purification. Meanwhile, 
the number of cDNAs truncating at the positions A and B is dramatically decreased under 
conditions that inhibit splicing progression and lariat formation: PRPF8 KD in vivo (2-fold, 
Fig. 2a), or absence of ATP in vitro (≥18-fold, Fig. 2b). This further confirms that 
spliceosome iCLIP can monitor spliceosome assembly at distinct stages of the splicing 
cycle.
Specific RBPs are enriched at each peak of spliceosomal crosslinking
Next, to identify RBPs that crosslink at peaks identified by spliceosome iCLIP, we examined 
the eCLIP data for 110 RBPs (from 157 eCLIP samples of 68 RBPs in the HepG2, and 89 
RBPs in the K562 cell line) provided by the ENCODE consortium16. Of note, comparisons 
between iCLIP and eCLIP are justified due to their use of identical lysis and wash buffers 
(analogous to medium stringency from the present study), use of truncated cDNAs to 
identify crosslink sites and similar RNase digestion conditions, and comparable crosslinking 
profiles for RBPs such as PTBP1 and U2AF215. Accordingly, we analyzed the eCLIP data 
to identify RBPs with enriched normalized crosslinking at each spliceosomal iCLIP peak. 
This identified a specific set of RBPs at each peak, with good overlap between RBPs 
identified in K562 and HepG2 cells (Fig. 3 and Supplementary Data Set 1). As expected, 
SF3 components SF3B4, SF3A3 and SF3B1 bind to peaks 4 or 518, U2AF2 binds the 
polypyrimidine (polyY) tract (peak 6), and U2AF1 close to the intron-exon junction (peak 
7)19.
Spliceosome iCLIP identifies BPs with canonical sequence and structural features
To determine whether spliceosome iCLIP could experimentally identify human BPs, we 
used spliceosome iCLIP data produced under medium purification from Cal51 cells. Most 
cDNA starts in spliceosome iCLIP overlap with a uridine-rich motif (Fig. 4a), in agreement 
with an increased propensity of protein-RNA crosslinking at uridine-rich sites14. In contrast, 
cDNAs ending at the last nucleotide of introns, which are thus likely derived from intron 
lariats, have starts overlapping the YUNAY motif matching the consensus BP sequence (Fig. 
4b). Further, these cDNAs have higher enrichment of mismatches of adenosines at their first 
nucleotide (Supplementary Fig. 3a), which is consistent with mismatch, insertion and 
deletion errors during reverse transcription across the three-way junction of the BP9. For 
comparison, reads that start in regions where BPs are typically located, but which do not 
align with intron ends, have less enrichment of the BP consensus motif at their starts 
(Supplementary Fig. 3b,c). To identify a confident set of putative BPs in a transcriptome-
wide manner, we therefore used the spliceosome iCLIP cDNAs that aligned with the end of 
introns (Fig. 4b). These cDNAs started at adenines in 132,287 intronic positions, which we 
considered as BP candidates. The 41 read-length limited our analysis to the region where 
most BPs are located, but more distal BPs cannot be identified by this approach. For further 
study, we selected BPs with the highest number of truncated cDNAs per intron. This 
identified candidate BPs in 43,637 introns of 9,565 genes.
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To examine the BPs identified by spliceosome iCLIP (‘iCLIP BPs’), we compared them 
with the ‘computational BPs’ recently identified with a sequence-based deep learning 
predictor, LaBranchoR, which predicted BPs for over 90% of 3'ss12. We also compared with 
‘RNA-seq BPs’, including the 138,314 BPs from 43,637 introns that were identified by 
analysis of lariat-spanning reads from 17,164 RNA-seq datasets8. Initially, 65% of iCLIP 
BPs overlapped with the top-scoring computational BPs (Supplementary Fig. 3d). 
Interestingly, in cases where iCLIP and computational BPs were located <5 nt apart, they 
frequently occurred within A-rich sequences (Supplementary Fig. 3e). This mismatch could 
be of technical nature, as truncation of iCLIP cDNAs may not always be precisely aligned to 
the BPs in case of A-rich sequences. Alternatively, more than one A might be capable of 
serving as the BP. When allowing a 1 nt shift for comparison between methods, as has been 
done previously12, 70% of iCLIP BPs overlapped with the top-scoring computational BPs, 
whilst 26% overlapped with the RNA-seq BPs (Fig. 4c, Supplementary Data Set 2). If the 
computational BPs overlapped either with an iCLIP BP and/or RNA-seq BP, it generally had 
a strong BP consensus motif (o-BP, Fig. 4d).
To gain insight into the differences between the methods, we focused on BPs that were 
identified by a single method and located >5 nt away from BPs identified by other methods. 
Notably, the computational- or iCLIP-specific BPs have a strong enrichment of the 
consensus YUNAY motif (c-BP, i-BP, Fig. 4e,f,h,i). In contrast, RNA-seq-specific BPs 
contain a larger proportion of non-canonical BP motifs, which agrees with previous 
observations7,9,12 (Fig. 4g,j). To evaluate further, we compared iCLIP BPs with two studies 
that identified 59,359 BPs by exoribonuclease digestion and targeted RNA-sequencing9, and 
36,078 BPs by lariat-spanning reads refined by U2 snRNP/pre-mRNA base-pairing models7. 
Considering the introns that contained BPs defined both by RNA-seq and iCLIP, we found 
57% and 47% overlapping BPs (Supplementary Fig. 3f-i). Again, the iCLIP-specific BPs 
were more strongly enriched in the consensus YUNAY motif compared to BPs specifically 
identified by either RNA-seq method (Supplementary Fig. 3j-o). We also examined the local 
RNA structure around each category of BPs. Overlapping, iCLIP-specific and 
computational-specific BPs had a decreased pairing probability at the position of the BP, 
which was not seen for the RNA-seq-specific BPs (Fig. 4k,l). The difference in RNA-seq 
BPs derives from the presence of non-canonical, non-A branched BPs, which have a 
generally increased pairing probability (Supplementary Fig. 3p,q). This indicates that the 
non-A BPs might be structurally less accessible for pairing with U2 snRNP.
Alignment of RBP binding profiles signifies the functionality of BPs
Peaks 4, 5 and position B align to BP position, and therefore we could evaluate how the 
crosslinking profiles of RBPs binding at these peaks align to the different classes of BPs. 
First, we examined the crosslinking of SF3B4, which binds in the region of peak 4 as part of 
the U2 snRNP complex that recognises the BP1. Analysis of the overlapping BPs (o-BP) 
defines the peak of SF3B4 crosslinking at the 25th nt upstream of BPs (Fig. 5 and 
Supplementary Fig. 4a,b). However, the peak of SF3B4 crosslinking is shifted from this 25th 
position for the non-overlapping, method-specific BPs; it is generally closer than 25 nt to the 
BPs located upstream of another BP (up BP), and further than 25 nt away from BPs located 
downstream of another BP (down BP) (Fig. 5). The shift from the expected position is 
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greatest for RNA-seq-specific BPs (R-BP), and smallest for computationally predicted BPs, 
as evident by eCLIP data from two cell lines (Fig. 5a,b). Moreover, the same result is seen 
with U2AF2, where the strongest shift away from expected positions is seen for RNA-seq 
BPs, and weakest for computational BPs (Supplementary Fig. 4c,d). The cDNA starts from 
PRPF8 eCLIP are highly enriched at position B, corresponding to the lariat-derived cDNAs 
that truncate at BPs (Fig. 3). Interestingly, the PRPF8 cDNA starts had the strongest peak at 
the overlapping BPs, but also peaked at all the remaining classes of BPs (Supplementary 
Fig. 4e,f). This indicates that all classes of BPs contribute to lariat formation, and that the 
non-overlapping BPs most likely act as alternative BPs within the introns.
Effects of BP position on spliceosomal assembly
To assess how BP positioning determines spliceosome assembly, we evaluated binding 
profiles of the RBPs that are enriched at peaks 4-7 and at positions A and B (Fig. 3). We 
divided BPs based on their distance from 3'ss, and normalized RBP binding profiles within 
each subclass of BP. This showed that crosslinking of U2AF1 and U2AF2 aligns to the 
region between the BPs and 3'ss, which is covered by the polyY tract (Supplementary Fig. 5 
and 6). Whilst SF3B4 is the primary RBP crosslinking at peak 4, and SF3A3 at peak 5, 
binding of SMNDC1, SF3B1, EFTUD2, BUD13, GPKOW and XRN2 to peaks 4 and 5 was 
also evident (Supplementary Fig. 5, 6 and Fig. 3). PRPF8, RBM22 and SUPV3L1 have their 
cDNA starts truncating at positions A and B (Supplementary Fig. 5 and 6), corresponding to 
the three-way junction formed by intron lariats (Fig. 2c). This is in agreement with the 
association of PRPF8 and RBM22 with intron lariats as part of the human catalytic step I 
spliceosome1. The positions of SF3B4 and SF3A3 crosslinking peaks also agree with 
CryoEM studies of the human spliceosome that show closer pre-mRNA binding of SF3A3 
(also referred to as SF3a60) to the BP compared to SF3B4 (also referred to as SF3b49)20.
In order to quantify how BP positioning affects the intensity of RBP binding, we divided 
BPs into 10 equally sized groups based on the distance from 3'ss. We then normalized the 
relative binding intensity of each RBP at each position on the RNA maps across the ten 
groups, and revealed strong relationships between BP position and binding intensity of 
certain RBPs (Fig. 6a, Supplementary Fig. 7a). For example, if a BP is located distally from 
the 3'ss, then U2AF components bind stronger to peaks 6 and 7. In contrast, if a BP is 
located proximally to the 3'ss, then EFTUD2, SF3 components and several other RBPs bind 
stronger to the peaks 4 or 5 (Fig. 6b). Notably, increased BP distance causes increased 
binding of BUD13 and GPKOW at peaks 6 or 7 and decreased binding at peaks 4 and 5. The 
more efficient recruitment of U2AF and associated factors to peaks 6 and 7 could be 
explained by the long polyY-tracts at distal BPs (Supplementary Fig. 5), while their 
decreased binding at proximal BPs appears to be compensated by increased binding of SF3 
and other U2 snRNP-associated factors at peaks 4 and 5.
In contrast to effects on individual splicing factors, we did not observe any effect of BP 
distance on the relative intensity of spliceosome iCLIP crosslinking in peaks 4 and 5 
compared to 6 and 7 (Fig. 6c). This indicates that the effects may be masked during later 
stages of spliceosome assembly. To ask if this is the case, we turned to PRPF8, a protein that 
is essential for later stages of spliceosomal assembly, a role it plays together with EFTUD2 
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and BRR2 as part of U5 snRNP1. PRPF8 KD leads to decreased spliceosomal binding at 
peaks 4 and 5, and this effect is stronger at distal compared to proximal BPs (Fig. 6c). In 
conclusion, our results reveal differences in the binding profiles of splicing factors in 
relation to BP distance, but these differences are neutralized upon full spliceosome assembly 
in a manner that requires the presence of PRPF8.
Effects of BP strength on spliceosomal assembly
To examine how BP strength affects spliceosomal assembly we focused on BPs that have 
been identified both by spliceosome iCLIP and computational modelling, and which are 
located at 23-28 nt upstream of the 3'ss. Of note, this is the most common position of BPs 
(Supplementary Data Set 3). As an estimate of BP strength we used the BP score, which was 
determined with a deep-learning model12. This showed strong correlation between BP 
strength and RBP binding intensities, such that most RBPs have increased crosslinking at 
peaks 4 and 5 at BPs with very high scores, and, conversely, increased crosslinking at peaks 
6 and 7 at BPs with very low scores (Fig. 7a,b, Supplementary Fig. 7b). Since SF3 
components primarily bind at peaks 4 and 5, and U2AF components at peaks 6 and 7, an 
over 4-fold change is seen in the ratio of crosslinking when comparing the extreme deciles 
of BP strength (Supplementary Fig. 7c). We did not observe any correlation between the 
polyY tract coverage and BP score (Supplementary Fig. 7d), which indicates that BP 
strength directly affects the RBP binding profiles.
Similar to the effects on individual splicing factors, the relative intensity of spliceosome 
iCLIP crosslinking in peaks 4 and 5 was increased with increasing BP strength (Fig. 7c, 
compare blue lines on the left and right graphs). PRPF8 KD decreased spliceosomal binding 
at peaks 4 and 5 of both classes of BPs, and this led to stronger crosslinking at peaks 6 and 7 
relative to peaks 4 and 5 at weak BPs, even though the peaks 4 and 5 are usually stronger. 
The signal at position B of weak BPs is almost completely lost upon PRPF8 KD, which 
likely reflects the absence of intron lariats due to perturbed splicing of introns with weak 
BPs (Fig. 7c). In conclusion, our results suggest that the assembly efficiency of spliceosomal 
factors at peaks 4 and 5 closely correlates with BP strength, which indicates that recognition 
of weak BPs might be more sensitive to perturbed spliceosome function.
Discussion
Here we established spliceosome iCLIP to study the interactions of endogenous snRNPs and 
accessory splicing factors on pre-mRNAs. We identified peaks of spliceosomal protein-pre-
mRNA interactions, which precisely overlap with crosslinking profiles of 15 splicing 
factors. Interestingly, the contacts of RBPs in peaks 4 and 5 don’t overlap with any sequence 
motif, and thus the constrained conformation of the larger spliceosomal complex appears to 
act as a molecular ruler that positions each associated RBP on pre-mRNAs at a specific 
distance from BPs. Moreover, the presence of lariat-derived reads in spliceosome iCLIP 
identified >40,000 BPs that have canonical sequence and structural features. Due to the 
precise alignment of splicing factors relative to the positions of BPs, we could use their 
binding profiles to show that the assembly of U2 snRNP is primarily coordinated by the 
computationally predicted BPs, whilst alternative BPs, identified only by iCLIP or RNA-seq, 
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are more rarely used. Finally, we reveal the major effect of the position and strength of BPs 
on spliceosomal assembly, which can explain why distally located or weak BPs are 
particularly sensitive to perturbed spliceosome function upon PRPF8 KD. These findings 
demonstrate the broad utility of spliceosome iCLIP for simultaneous and transcriptome-wide 
analysis of the assembly of diverse spliceosomal components.
The value of spliceosome iCLIP for identifying BPs
Both RNA-seq and iCLIP identify BPs by analyzing cDNAs derived from intron lariats. 
Thus, the efficiency of these methods depends on the abundance of intron lariats, which 
depends on the kinetics of lariat debranching. Several studies demonstrated that lariats 
formed at non-canonical BPs are less efficiently debranched21–23, and therefore these non-
canonical BPs are expected to be more efficiently detected. This is especially true for RNA-
seq-based methods, because they monitor steady state RNA levels. In contrast, iCLIP only 
captures lariats in complex with spliceosomes, thus minimizing bias for lariats that are stable 
after their release from the spliceosome. This could explain why the BPs identified by iCLIP 
contain a stronger consensus sequence than BPs identified from lariat-spanning reads in 
RNA-seq. The further value of spliceosome iCLIP is that, in addition to experiments under 
the medium condition that permit BP identification through lariat-derived cDNAs, 
experiments under the mild condition identify the SF3 complex and other U2 snRNP-
associated RBPs that crosslink at peaks 4 and 5. These can crucially be used to 
independently validate the functional role of BPs in the assembly of U2 snRNP. Thus, use of 
spliceosome iCLIP under both conditions, combined with computational modelling of 
BPs12, is well suited to studying the functionality of BPs.
The role of BP position and strength in spliceosomal assembly
We show that BP position and the computationally defined strength of BPs correlate with the 
relative binding of splicing factors around BPs. This is exemplified by strong binding of SF3 
components at strong BPs, or BPs located close to 3'ss, whilst U2AF components bind 
stronger to weak BPs, or BPs located further from 3'ss (Fig. 7d). In the cases of SF3B1, 
BUD13 and GPKOW, we observed enriched binding at peaks 4 and 5 as well as 6 and 7, 
with reciprocal changes between the two peak regions dependent on BP features (Fig. 6 and 
7). These RBPs are not known to bind at peaks 6 or 7, and it is plausible that the signal at 
some peaks represents binding of U2AF or other spliceosomal factors that are co-purified 
during eCLIP. It is presently not possible to fully distinguish between direct and indirect 
binding from eCLIP data, because purified protein-RNA complexes have not been visualized 
after their separation on SDS-PAGE gels in eCLIP13. Nevertheless, it is clear that BP 
characteristics determine the balance between binding of SF3 and associated factors at peaks 
4 and 5 and of U2AF and associated factors at peaks 6 and 7. This suggests further study of 
RBP binding profiles around BPs could unravel a BP ‘code’ that facilitates specific stages of 
BP recognition and function.
In conclusion, spliceosome iCLIP monitors concerted pre-mRNA binding of many types of 
spliceosomal complexes with nucleotide resolution, allowing their simultaneous study due to 
the distinct position-dependent binding pattern of components acting at multiple stages of 
the splicing cycle. The method can now be used to study the endogenous spliceosome and 
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BPs across tissues, species and stages of development without need for the protein tagging 
used in yeast3,4. Further, several spliceosomal components, including U2AF1, SF3B1 and 
PRPF8, are targets for mutations in myeloid neoplasms, retinitis pigmentosa and other 
diseases24. Spliceosome iCLIP could now be used to monitor global impacts of these 
mutations on spliceosome assembly in human cells. More generally, our study demonstrates 
the value of iCLIP for monitoring the position-dependent assembly and dynamics of multi-
protein complexes on endogenous transcripts.
Online Methods
Cell culture
Flp-In HEK293 T-REx cells were from ThermoFisher (R78007), K562, HepG2 and standard 
HEK293 cells were obtained from the Francis Crick Cell Services Science Technology 
Platform, and Cal51 breast adenocarcinoma cells were obtained from DSMZ (reference 
14563). All cell lines tested negative for Mycoplasma contamination. HEK293 and HepG2 
were cultured in DMEM with 10% FBS (ThermoFisher) and 1× penicillin-streptomycin 
(ThermoFisher). K562 cells were cultured in RPMI 1640 (IMDM, ATCC) with 10% FBS 
and 1× penicillin-streptomycin. Cal51 cells were cultured in DMEM (ThermoFisher) with 
10% fetal calf serum (FCS, ThermoFisher) and 1× penicillin-streptomycin (ThermoFisher).
To generate a plasmid encoding 3×Flag epitope-tagged SmB, the SmB cDNA was amplified 
using Phusion High-Fidelity DNA polymerase (NEB) with primers carrying the KpnI and 
NotI restriction enzymes sites and cloned using Rapid DNA Ligation Kit (Thermo Fisher 
Scientific) into a pcDNA5/FRT/TO vector modified to encode 3×Flag peptide upstream of 
the multiple cloning site. To produce stable cell lines expressing this construct, the 
pcDNA5/FRT/TO plasmid with 3×Flag epitope-tagged SmB was co-transfected with pOG44 
plasmid into Flp-In HEK293 T-REx cells (ThermoFisher, R78007). Cells stably expressing 
these proteins were selected by culturing in Dulbecco’s Modified Eagle Medium (DMEM, 
Thermofisher) containing 10% fetal bovine serum (FBS), 3 μg/ml Blasticidine S HCl, 200 
μg/ml Hygromycine (InvivoGen). Flp-In 293 T-REx cells (Life Technologies) were cultured 
in DMEM with 10% FBS, 3 μg/ml Blasticidin S HCl (Life Technologies), 50 μg/ml Zeocin 
(Life Technologies). Doxycycline was added to media 24 hours prior to sample preparation 
in order to induce construct expression.
Cal51 breast adenocarcinoma cells were prepared as described previously5. For siRNA-
mediated depletion of PRPF8, Cal51 cells were transfected using DharmaFECT1 
(Dharmafect) with 25 nM siRNA targeting human PRPF8. Transfected cells were harvested 
54 hrs later, exposed to UV-C light and used for iCLIP as described below. For collection of 
samples from different stages of the cell cycle, Cal51 cells were synchronized in G1/S by 
standard double thymidine block. Briefly, cells were treated with 1.5 mM thymidine for 8 
hrs, washed and released for 8 hrs, then treated again with thymidine for a further 8 hrs. 
Cells were also collected 3 hrs (S-phase) and 7 hrs (G2) after release from the thymidine 
block.
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Antibody production
For production of the anti-SmB/B’ monoclonal antibody 18F6, Balb/c females were primed 
with Immuneasy adjuvant (Qiagen) and 25 mg of 6×His-SmB purified recombinant proteins. 
Following two boosts at two-week intervals, SP2 myeloma cells were fused with mouse 
splenocytes and hybridoma supernatants were analyzed onto antigen-coated aminosilane 
modified slides using a LS400 Scanner (Tecan) and the GenePix Pro 4.1 software as 
described previously10. Hybridoma cells were subcloned by limiting dilution and further 
screened by ELISA, Western blot and immunofluorescence analysis of HeLa cells.
In vitro splicing
For in vitro splicing reactions, a C6orf10 minigene construct containing exon 8 and 9 and 
150 nt of the intron around both splice sites was produced (Fig. 2b). The minigene plasmid 
was linearized and transcribed in vitro using T7 polymerase with 32P-UTP. The transcribed 
RNA was then subjected to in vitro splicing reactions using HeLa nuclear extract. HeLa 
nuclear extract was depleted of endogenous ATP by pre-incubation and, for each reaction, 
10 ng of RNA was incubated with 60% HeLa nuclear extract at 30°C with or without 
additional 0.5 mM ATP for 1 h in a 20 µl reaction. Afterwards, the reaction mixture was UV-
crosslinked at 100 mJ/cm2 and stored at -80°C until further use. To visualize the splicing 
reaction products, proteinase K was added to the reaction mixture for 30 min at 37°C. The 
resulting RNA was phenol-extracted, precipitated and subjected to gel electrophoresis on a 
5% polyacrylamide-urea gel.
Spliceosome iCLIP protocol
For each experiment, three biological replicate samples of cDNA libraries were prepared 
(Supplementary Tables 2 and 3). The iCLIP method was done as previously described11, 
with the following modifications. Crosslinked cells or tissue were dissociated in the lysis 
buffer according to the stringency conditions (stringent, medium, mild; Supplementary Table 
1) followed by sonication, low RNase I (AM2295, 100 U/µl, ThermoFisher) digestion and 
centrifugation. RNase at low concentration ensured that cDNAs are of optimal size for 
comprehensive crosslink determination15. For denaturing, high-stringency experiment11, M2 
anti-Flag antibody (Sigma) was used against the 3×Flag-SmB protein that had been stably 
integrated into HEK-293 FlpIn cells (Supplementary Fig. 1c). 6M Urea buffer was first used 
to lyse cell pellets, before being diluted down 1:9 with a Tween-20-containing IP buffer to 
allow for immunopurification without denaturing of the M2 anti-Flag antibody, and then 
proceeded as described previously15.
Standard iCLIP protocol11 was used for Cal51 cells under mild and medium stringency 
conditions, and for the in vitro splicing reactions under mild conditions, whilst an updated 
protocol was used for HEK293, HepG2 and K562 cells26. For SmB/B' immunopurification 
anti-SmB/B' antibodies 12F5 (sc-130670, Santa Cruz Biotechnology for Cal51 cells, and 
S0698, Sigma-Aldrich for HEK293, HepG2 and K562 cells) or 18F6 (as hybridoma 
supernatant, generated as described previously10) were used, which are different clones from 
the same immunization. These antibodies behave identically under immunopurification 
conditions (Supplementary Fig. 1d). For spliceosome iCLIP from in vitro splicing reactions 
(Supplementary Fig. 2c,d), lysates were incubated with 50 μl monoclonal anti-SmB/B' 
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antibody 18F6, and for immunoprecipitations from cell lysates, 12F5 anti-SmB/B' antibody 
was used. The antibody was bound to 100 μl protein G Dynabeads (ThermoFisher) under 
rotation at 4°C followed by washing. As described previously, following 
immunopurification, RNA 3' end dephosphorylation, ligation of the adapter 5'-
rAppAGATCGGAAGAGCGGTTCAG/ddC/-3' to the 3' end and 5' end radiolabeling, 
protein-RNA complexes were size-separated by SDS-PAGE and transferred onto 
nitrocellulose membrane. The regions corresponding to 28-180 kDa were excised from the 
membrane in order to isolate the bound RNA by proteinase K treatment. RNAs were 
reverse-transcribed in all experiments using SuperScript III or IV reverse transcriptase 
(ThermoFisher) and custom indexed primers (Supplementary Table 2). Resulting cDNAs 
were subjected to electrophoresis on a 6% TBE-urea gel (ThermoFisher) for size selection. 
Purified cDNAs were circularized, linearized and amplified for high-throughput sequencing.
Identification of protein crosslink sites around splice sites, in particular at the peaks 4 and 5, 
was most efficient under the mild purification condition (Supplementary Fig. 2a). This 
condition was therefore used for analysis of spliceosomal assembly upon PRPF8 knockdown 
in Cal51 cells (Fig. 2a), and in the in vitro splicing reactions in HeLa nuclear extract (Fig. 
2b). For the identification of BPs, we additionally used the medium condition, since it 
increases the frequency of cDNAs truncating at peak B (Supplementary Fig. 2a). For this 
purpose, spliceosome iCLIP was performed under medium purification conditions from 
Cal51 cells synchronized in G1, S and G2 phase. To maximize cDNA coverage, data from 
all synchronized cells was merged with the control Cal51 cells under mild condition for BP 
identification.
Mapping of Sm iCLIP reads
We mapped iCLIP data to the GRCh38 primary assembly and GENCODE v27 gene 
annotations using STAR (v.2.2.1). Experimental and random barcode sequences of iCLIP 
sequenced reads were removed prior to mapping (Supplementary Table 2). Following 
mapping, we used random barcodes to quantify the number of unique cDNAs at each 
genomic position by collapsing cDNAs with the same random barcode that mapped to the 
same starting position to a single cDNA. For analysis of crosslinking to snRNAs, we first 
mapped to a transcriptome of all annotated snRNA sequences in GENCODE v27 using 
Bowtie2 (v2.3.4.3), and kept the primary alignment. Unmapped reads were then mapped 
with STAR as previously described and intersected with GENCODE v27 for subtype 
analysis, with reads from Bowtie2 being added to the total snRNA count. For spliceosome 
iCLIP with the C6orf10 in vitro splicing substrate, sequence reads were first mapped to the 
unspliced substrate and the remaining reads were mapped to the spliced substrate allowing 
no mismatches. The nucleotide preceding the iCLIP cDNAs was used to define the crosslink 
sites in all analyses.
Mapping of eCLIP reads
For eCLIP sequencing data for all RBPs, we used GENCODE (GRCh38.p7) genome 
assembly and the STAR alignment (version 2.4.2a) using the following parameters from 
ENCODE pipeline: STAR --runThreadN 8 --runMode alignReads --genomeDir GRCh38 
Gencode v25 --genomeLoad LoadAndKeep --readFilesIn read1, read2, --readFilesCommand 
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zcat --outSAMunmapped Within –outFilterMultimapNmax 1 --
outFilterMultimapScoreRange 1 --outSAMattributes All --outSAMtype BAM Unsorted –
outFilterType BySJout --outFilterScoreMin 10 --alignEndsType EndToEnd --
outFileNamePrefix outfile.
For the PCR duplicates removal, we used a python script ’barcode collapse pe.py’ available 
on GitHub (https://github.com/YeoLab/gscripts/releases/tag/1.0), which is part of the 
ENCODE eCLIP pipeline (https://www.encodeproject.org/pipelines/ENCPL357ADL/).
Normalization of crosslink positions for their visualization in the form of RNA maps
RNA maps and heat maps were produced by summarizing the cDNA counts at each 
nucleotide using the previously developed RNA maps pipeline15,27 relative to exon-intron 
and intron-exon boundaries and BPs on pre-mRNAs. The definition of intronic start and end 
positions was based on Ensembl version 75. Only introns longer than 300 nt were used to 
draw RNA maps in order to avoid detection of any RBPs that recognize 5'ss of introns.
In cases where we wished to compare the relative positions of crosslinking peaks between 
RBPs, we regionally normalized the summarized crosslinking of each RBP relative to the 
average crosslinking of the same RBP across the region 100 nt upstream and 50 nt 
downstream of the evaluated splice sites or BPs. Normalized values were then used to 
visualize the crosslinking in the form of RNA maps (Fig. 2, Supplementary Fig. 5 and 6). 
The same normalization was then used to plot heat maps, by plotting mean values of 
normalized RNA maps for each peak in the following regions; peak 4: -29..-23 nt and peak 
5: -21..-17 nt relative to BP, peak 6: -11..-5 nt and peak 7: -3..-1 nt relative to 3'ss. Every 
RBP was then normalized by the mean across all the peaks to visualize crosslinking 
enrichment between the groups on the same scale across all RBPs (Fig. 6 and 7, 
Supplementary Fig. 7).
To assess the role of BP characteristics on spliceosomal RBP assembly (Fig. 4, 6 and 7), we 
only examined the introns containing the 31,167 BPs that were identified both 
computationally and by iCLIP, which are likely the most reliable. We divided BPs into 10 
categories based on BP position or score, and then normalized the summarized crosslinking 
of each RBP in each of the 10 BP categories relative to the average crosslinking of the same 
RBP across the region 100 nt upstream and 50 nt downstream of all the 31,167 evaluated 
BPs.
For visualization of spliceosome iCLIP crosslinks along the C6orf10 in vitro splicing 
substrate and product (Fig. 2b and Supplementary Fig. 2e) we first summed the cDNA starts 
at each nt position and then normalized the counts by the average number of cDNA starts in 
the intronic region 101..150 relative to the 5'ss of the unspliced substrate. For the unspliced 
substrate normalized cDNA counts were logarithmized (log2) and data with log2(normalized 
number of cDNA starts)≥1 were plotted. For the spliced product normalized cDNA counts 
were plotted.
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Identification and comparison of BPs
It has been shown that the spliceosomal C complexes harbor a salt-resistant RNP core 
containing U2, U5 and U6 snRNAs as well as the splicing intermediates including lariats 
that withstand treatment with 1M NaCl, whereas the spliceosomal B complexes were more 
likely dissociated under high-salt conditions17. This could explain why the medium 
purification condition is more suited than the mild condition to enrich for lariat cDNAs 
truncating at position B (Supplementary Fig. 2a). It is conceivable that the medium 
spliceosome iCLIP condition most strongly enriches spliceosomal C complexes, which are 
most effective for lariat detection. In contrast, the mild condition is expected to enrich 
additional B complexes that contain large amounts of SF3 components and have low 
proportion of lariats, in agreement with the strong enrichment of peaks 4 and 5 
(Supplementary Fig. 2a). To identify the maximal diversity of BPs, we therefore pooled 
spliceosome iCLIP data produced under mild and medium purification conditions from 
Cal51 cells.
To identify BPs we used the spliceosome iCLIP reads that ended precisely at the ends of 
introns (we considered only introns that end in AG dinucleotide) after removal of the 3' 
adapter. We noticed that these reads had an 3.5× increased frequency of mismatches on the 
A as the first nucleotide compared to remaining iCLIP reads (Supplementary Fig. 3a), 
indicating that these mismatches may have resulted from truncation at the three-way-
junction formed at the BP (Fig. 2c). We therefore trimmed the first nucleotide from the read 
if it contained a mismatch at the first position that corresponded to a genomic adenosine. We 
then used spliceosome iCLIP from Cal51 cells to identify all reads that ended precisely at 
the ends of introns and defined the position where these reads started and assessed the 
random barcode nucleotides that are present at the beginning of each iCLIP read to count the 
number of unique cDNAs at each position. The nucleotide preceding the read start 
corresponds to the position where cDNAs truncated during the reverse transcription, and we 
selected the genomic A that had the highest number of truncated cDNAs as the candidate 
BP. If two positions with equal number of cDNAs were found, we selected the one closer to 
the 3'ss. Together, this identified 43,637 BPs.
We also attempted to use truncated cDNAs from PRPF8 eCLIP for discovery of BPs, but 
found that the number of cDNAs overlapping with intron ends was much smaller than in 
spliceosome iCLIP, and was insufficient for BP discovery. This is most likely because of the 
high amount of non-specific background signal in PRPF8 eCLIP, which leads to a lower 
proportion of cDNAs that align to the BPs.
Bedtools Intersect command using option –u was used to compare BP coordinates from 
spliceosome iCLIP to the BPs identified in previous studies. We restricted this comparison 
to introns where BPs were detected by all three datasets (iCLIP, RNA-seq and computational 
prediction).
To define a single ‘computational BP’ per intron, the BP positions computationally predicted 
for each intron in hg19 were obtained from http://bejerano.stanford.edu/labranchor/, and the 
top scoring BP in each intron was used. To define a single ‘RNA-seq BP’ per intron, we 
used the BP with most lariat-spanning reads in each intron.
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Analysis of pairing probability
Computational predictions of the secondary structure were performed by RNAfold function 
from Vienna Package (https://www.tbi.univie.ac.at/RNA/) with default parameters25. The 
RNAfold results are provided in a customized format, where brackets are representing the 
double-stranded region on the RNA and dots are used for unpaired nucleotides. We 
measured the density of pairing probability by summing the paired positions into a single 
vector.
Identification of RBPs overlapping with spliceosomal peaks
For RBP enrichment in Fig. 3, we used the eCLIP data from the ENCODE consortium16, 
together with available iCLIP experiments from our lab (which are all listed in 
Supplementary Data Set 4), to see if any of the proteins are enriched in the region of 
spliceosomal peaks. In total, this included 157 eCLIP samples of 68 RBPs in the HepG2 cell 
line, and 89 RBPs in the K562 cell line, and iCLIP samples of 18 RBPs from different cell 
lines (Supplementary Data Set 4). Next, we intersected cDNA starts from each sample to the 
-100 to +50 nt region relative to the 3'ss and used it as control for each of the following 
peaks: Peak 4 (-23 nt..-29 nt relative to BP), Peak 5 (-21 nt..-17 nt relative to BP), Peak B (-1 
nt..1 nt relative to BP), Peak A (-1 nt..1 nt relative to 5'ss), Peak 6 (-11 nt..-10 nt relative to 
3'ss), Peak 7 (-3 nt..-2 nt relative to 3'ss). The positions of these peaks were determined 
based on crosslink enrichments in spliceosome iCLIP.
Statistics
All statistical analyses were performed in the R software environment (version 3.1.3 and 
3.3.2, https://www.r-project.org).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Spliceosome iCLIP identifies protein interactions with snRNAs and splicing substrates.
(a) Schematic representation of the spliceosome iCLIP method performed under conditions 
of varying purification stringency.
(b) Autoradiogram of crosslinked RNPs immunopurified from HeLa cells under medium 
conditions by a SmB/B' antibody following digestion with high (++) or low (+) amounts of 
RNase I. The dotted line depicts the region typically excised from the nitrocellulose 
membrane for spliceosome iCLIP. As control, the antibody (Ab) was omitted during 
immunopurification.
(c) Genomic distribution of spliceosome iCLIP cDNAs produced under stringent, medium 
and mild conditions from HEK293 cells. Data was mapped first to snRNAs, allowing 
multiple mapping reads, and then to the genome, allowing only uniquely mapped reads. 
Proportions of cDNAs mapping to snRNAs, introns, coding sequence of mRNAs (CDS), 
untranslated regions of mRNAs (UTR) and long non-coding RNAs (lncRNAs) are shown 
(but not the intergenic reads and other types of RNAs). Data are shown as mean±s.e.m from 
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three independent experiments for the medium and mild purification condition and two 
independent experiments for the stringent purification condition. Source data for panel c are 
available online.
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Fig. 2. Analysis of spliceosomal interactions with pre-mRNAs in vitro and in vivo.
(a) Metagene plots of spliceosome iCLIP from Cal51 cells. Plots are depicted as RNA maps 
of summarized crosslinking at all exon-intron and intron-exon boundaries, and around BPs 
to identify major binding peaks, and to monitor changes between control and PRPF8 
knockdown (KD) cells. Crosslinking is regionally normalized to its average crosslinking 
across the -100..50 nt region relative to splice sites or BPs depending on the RNA map in 
order to focus the comparison on the relative positions of peaks.
(b) Normalized spliceosome iCLIP cDNA counts on the C6orf10 in vitro splicing substrate. 
Exons are marked by grey boxes, intron by a line, and the BP by a green dot. The positions 
of crosslinking peaks are marked by numbers and letters corresponding to the peaks in 
Figure 2a.
(c) Schematic description of the three-way junctions of intron lariats. The three-way junction 
is produced after limited RNase I digestion of intron lariats. This can lead to cDNAs that 
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don’t truncate at sites of protein-RNA crosslinking, but rather at the three-way junction of 
intron lariats. These cDNAs initiate from the end of the intron and truncate at the BP 
(position B), or initiate downstream of the 5'ss and truncate at the first nucleotide of the 
intron (position A).
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Fig. 3. Identification of RBPs overlapping with spliceosomal peaks at BPs and 3'ss.
Enrichment of eCLIP crosslinking within each of the spliceosome iCLIP peaks, which are 
defined by the positions marked in the figure. We first regionally normalized the 
crosslinking of each RBP to its average crosslinking over -100..50 nt region relative to 3'ss, 
which generates the RNA maps as shown in Supplementary Fig. 5 and 6. We then ranked the 
RBPs according to the average normalized crosslinking across the nucleotides within each 
peak. We analyzed peaks 4-7 and positions A and B, as marked on the top of each plot. The 
top-ranking RBPs in each peak are shown on the left plot, and the full distribution of RBP 
enrichments is shown on the right plot.
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Fig. 4. Comparison of BPs identified by spliceosome iCLIP, RNA-seq lariat reads or 
computational prediction.
(a) Weblogo around the nucleotide preceding all spliceosome iCLIP reads.
(b) Weblogo around the nucleotide preceding only those spliceosome iCLIP reads that align 
with ends of introns.
(c) Introns that contain at least one BP identified either by published RNA-seq8 or by 
spliceosome iCLIP are used to examine the overlap between the top BPs identified by RNA-
seq (i.e., the BP with most lariat-spanning reads in each intron), iCLIP (BP with most cDNA 
starts) or computational predictions (highest scoring BP)12. BPs that are 0 or 1 nt apart are 
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considered as overlapping. At the right, BP categories that are used for all subsequent 
analyses are defined, along with their acronyms. If a BP defined by one method is >5 nt 
upstream of a BP defined by another method, then ‘up’ is added to its acronym, and if it is 
>5 nt downstream, ‘down’ is added.
(d) Weblogo of o-BP category of BPs.
(e) Weblogo of C-BPup category of BPs.
(f) Weblogo of i-BPup category of BPs.
(g) Weblogo of R-BPup category of BPs.
(h) Weblogo of C-BPdown category of BPs.
(i) Weblogo of i-BPdown category of BPs.
(j) Weblogo of R-BPdown category of BPs.
(k, l) The 100 nt RNA region centered on the BP was used to calculate pairing probability 
with the RNAfold program using default parameters25, and the average pairing probability 
of each nucleotide around BPs is shown for the 40 nt region around method-specific BPs 
located upstream (k) or downstream (l).
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Fig. 5. Spliceosome assembly at BPs identified by spliceosome iCLIP, RNA-seq lariat reads or 
computational prediction.
Violin plots depicting the positioning of SF3B4 cDNA starts relative to the indicated BP 
categories. SF3B4 eCLIP data were from K562 (a) and HepG2 (b) cells. Box-plot elements 
are defined by center line, median; box limits, upper and lower quartiles; and whiskers, 1.5× 
interquartile range. Each data point corresponds to an eCLIP crosslink event, and the total 
number of eCLIP crosslinks that map in the area analysed around each set of BPs (sample 
size) is shown under the plot.
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Fig. 6. BP position defines the binding patterns of splicing factors at 3'ss.
(a) Heatmaps depicting the normalized crosslinking of RBPs in peak regions around 10 
groups of BPs that were categorized according to the distance of the BP from 3'ss. 
Crosslinks were derived as cDNA starts from eCLIP of HepG2 cells.
(b) RNA maps showing normalized crosslinking profiles of selected RBPs relative to BPs 
and 3'ss for the two deciles of BPs that are located most proximal (interrupted light lines) or 
most distal (solid dark lines) from 3'ss.
Briese et al. Page 26
Nat Struct Mol Biol. Author manuscript; available in PMC 2020 March 30.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
(c) RNA maps showing crosslinking profile of spliceosome iCLIP from control and PRPF8 
KD Cal51 cells in the same format as panel b.
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Fig. 7. BP strength correlates with the binding of splicing factors.
(a) Heatmaps depicting the normalized crosslinking of RBPs in peak regions around 10 
groups of BPs that were categorized according to the computational scores that define BP 
strength. Crosslinks were derived as cDNA starts from eCLIP of HepG2 cells.
(b) RNA maps showing normalized crosslinking profiles of selected RBPs relative to 3'ss for 
the two deciles of BPs that are lowest scoring (interrupted light lines) or highest scoring 
(solid dark lines).
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(c) RNA maps showing crosslinking profile of spliceosome iCLIP from control and PRPF8 
KD Cal51 cells in the same format as panel b.
(d) Schematic representation of the effects that BP position and score have on the assembly 
of SF3 and U2AF complexes around BPs.
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